The normal reproductive events of proliferation of the endometrial lin
ing of the uterus during the menstrual cycle and ovulation have been l
ikened to inflammatory-like events. The kallikrein-kinin system is inv
olved in inflammatory processes in many tissues. In this review, we id
entify which components of the kallikrein-kinin system - the enzyme, t
issue kallikrein; the substrate, low molecular weight kininogen and th
e effector receptor for the generated bradykinin peptide, the B2 recep
tor - have been identified in the uterus and ovary and their known inv
olvement in the function of these organs. All three components have be
en localized to the glandular, epithelial cells of the human endometri
um. Tissue kallikrein gene expression is elevated midcycle when estrog
ens levels are also rising. This is also a time of extensive endometri
al proliferation and tissue remodelling in preparation for embryo impl
antation, an event which is likened to other inflammatory processes. S
imilarly, tissue kallikrein gene expression was elevated following the
estrogen surge at proestrous in the rat uterus, suggesting tissue kal
likrein gene expression may be regulated by estrogens. Tissue kallikre
in enzyme activity and gene expression has been demonstrated in the ra
t ovary and shown to be variously altered at the time of ovulation. Br
adykinin has also been implicated in the expulsion of the ovum at the
time of ovulation. These findings show that various components of the
kallikrein-kinin system are present in the uterus and ovary. Further s
tudies are required to more fully delineate their role in reproductive
function. (C) 1997 The Italian Pharmacological Society.